Alpha Test supplement capsules recalled for unapproved cathine ingredient
Iovate Health Sciences is recalling Alpha Test 120-count capsules containing cathine, an unapproved ingredient not permitted in dietary supplements. Affected products were distributed across the United States and internationally.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The product contains cathine, an unapproved ingredient not permitted in dietary supplements, supporting FDA Class II classification. No illnesses or injuries are reported in the source text, limiting the severity to the maximum score for theoretical hazards without documented harm.
Plain-English summary
Alpha Test 120-count capsules manufactured by Iovate Health Sciences USA Inc. are being recalled due to the presence of cathine, an unapproved ingredient in dietary supplements. The product consists of 12 bottles per case, with 120 capsules per bottle, packaged in black-labeled plastic bottles.
Cathine is not approved for use in dietary supplements and poses a potential health risk to consumers. The recall affects 163,248 units distributed across multiple lot codes with expiration dates between March 21, 2027 and July 5, 2027.
The affected product was distributed domestically across 32 U.S. states (NC, CA, TX, NJ, VA, NV, PA, IN, NY, IL, MS, KY, MI, SC, WA, CT, FL, OH, WI, DE, LA, TN, MO, UT, GA, KS, CO, IA, AZ, OR) and internationally (ZA, PH, IS, KZ, AE). Consumers who have purchased this product should discontinue use immediately and contact the manufacturer regarding return or refund options.
The recalled product
- Product
- Alpha Test 120 count Black labeled plastic bottle, 12 bottles per case of 120 count capsules each per bottle, Store in a cool, dry place (60 F to 80 F), UPC 6-31656-60676-8, SKU0001191, SKU0002075
- Manufacturer
- Iovate Health Sciences USA Inc.
- Category
- Drug — Dietary Supplement
- Hazard
- cathine
- unapproved-ingredient
- stimulant
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Expiration Date and Lot Codes: March 21
- 2027 (Lots 24A125
- 24B059
- 24B060) March 22
- 2027 (Lot 24C112) July 3
- 2027 (Lots 24F164
- 24G112) July 4
- 2027 (Lot 24E288) July 5
- 2027 (Lots 24G243
- 24H207)
Distribution
Distributed in 30 states:
- AZ
- CA
- CO
- CT
- DE
- FL
- GA
- IA
- IL
- IN
- KS
- KY
- LA
- MI
- MO
- MS
- NC
- NJ
- NV
- NY
- OH
- OR
- PA
- SC
- TN
- TX
- UT
- VA
- WA
- WI
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27